Multiple Manufacturers

NEBUPENT

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Nebupent HCPCS:

J2545

HCPCS Code Descriptor:

Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg

Category:

J Code

Nebupent NDCs:

63323-0877-15, 13925-0522-01, 39822-3030-02, 13925-0515-10, 39822-3050-02

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Inhalation

Nebupent CPT Codes:

Potential CPT administration codes for Nebupent can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

13925-0515-10, 39822-3050-02

About Nebupent:

NEBUPENT is a medication manufactured by multiple manufacturers and aligned to the J Code: J2545. NEBUPENT is administered via the inhalation route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J2545 Added Date:

January 1, 1992

J2545 Effective Date:

January 1, 2008

J2545 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Nebupent billing and coding information.
Our team did not identify a source for Nebupent patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for NEBUPENT
Our team has not yet identified a source of side effects information for NEBUPENT. Please check back in a few weeks.